APOE and depressive symptom measurement: Our analytical sample consisted of 1748 participants (Fig. 1) who had complete data for our variables of interest (baseline MMSE, complaint, NPI anxiety and depression, comorbidity-polypharmacy score, social network, pTau/Aβ42 ratio, cortical thickness, APOE genotype, age, sex, and education).